[Determination of the tumor cell mass and its significance as a parameter for prognosis and therapy in patients with multiple myeloma].
In 19 patients with multiple myeloma tumor cell mass was determined. In addition the influence of tumor cell number on certain clinical parameters as well as on survival time has been analysed. In some patients the behaviour of tumor cell number in the course of different therapeutic regimen was studied. A close correlation between tumor cell mass on the one side and certain clinical parameters as well es more objective rationale for planning further therapy regimen can be obtained with the application of this method.
D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000188:drug therapy / Q000652:urine; D009194:Myeloma Proteins / Q000652:urine; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis
D009194:Myeloma Proteins; D003520:Cyclophosphamide; D011239:Prednisolone; D008558:Melphalan
Die Bestimmung der Tumorzellmasse und ihre Bedeutung als Parameter für Prognose und Therapie bei Patienten mit multiplem Myelom.